Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for blood loss reduction during elective cesarean section
ACTRN12615000312549Phase 4Completed
- Sponsor
- Ahmed Maged
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Estimated blood loss during and after cesarean section. Started Nov 2013; status: completed.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on ACTRN12615000312549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000312549.